Skip to main content
. 2019 Oct 30;74:e1237. doi: 10.6061/clinics/2019/e1237

Table 2. Clinical data of patients.

Factor Observation group (n=184) Control group (n=150) t/2/Z value p-value
Sex Male 124 (67.39) 102 (68.00) 0.014 0.906
Female 60 (32.61) 48 (32.00)
Age (years) 59.0±9.4 60.4±11.5 1.224 0.222
BMI (kg/m2) 23.15±1.82 23.04±1.97 0.529 0.567
Anamnesis
Hypertension 55 (29.89) 39 (41.49) 0.619 0.432
Diabetes mellitus 12 (6.52) 14 (9.33) 0.910 0.340
Hyperlipemia 24 (13.04) 23 (15.33) 0.358 0.549
COPD 16 (8.70) 10 (6.67) 0.474 0.491
Smoking history Yes 130 (70.65) 115 (76.67) 1.529 0.216
No 54 (29.35) 35 (23.33)
History of alcoholism Yes 20 (10.87) 11 (7.33) 1.227 0.268
No 164 (89.13) 139 (92.67)
Domicile City 152 (82.61) 130 (86.67) 1.035 0.309
Village 32 (17.39) 20 (13.33)
Total cholesterol (mmol/L) 4.45±1.10 4.23±0.94 1.939 0.053
Glycerin trilaurate (mmol/L) 1.91±0.93 1.84±0.0.7 0.762 0.446
LDL (mmol/L) 2.56±0.87 2.44±0.76 1.326 0.186
Creatinine (μmol/L) 71.44±11.90 70.18±11.02 0.995 0.320
Urea nitrogen (mmol/L) 6.24±1.52 6.15±1.06 0.614 0.540
cTn (ng/mL) 0.69±0.35 0.09±0.06 <0.001

Note: COPD: chronic obstructive pulmonary disease